ICON Public Limited Company (ICLR) Financials

ICLR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 16.3 billion 7.1 billion
Dec. 31, 2025 16.3 billion 7.1 billion
Sept. 30, 2025 16.5 billion 7.2 billion
June 30, 2025 16.6 billion 7.0 billion

ICLR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 622.7 million 89.7 million
Dec. 31, 2025 622.7 million 89.7 million
Sept. 30, 2025 351.9 million 60.2 million
June 30, 2025 127.6 million 15.3 million

ICLR Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 68.5 million
Dec. 31, 2025 68.5 million
Sept. 30, 2025 2.4 million
June 30, 2025 183.0 million

ICLR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 647.3 million - -
Dec. 31, 2025 647.3 million 2.9 billion 153.4 million
Sept. 30, 2025 468.9 million 2.9 billion 125.1 million
June 30, 2025 390.4 million 3.4 billion 132.7 million

ICLR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 79.0 million
Dec. 31, 2025 76.6 million
Sept. 30, 2025 78.1 million
June 30, 2025 79.5 million

ICLR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 145.3 million - - -
Dec. 31, 2025 145.3 million - 179.7 million -
Sept. 30, 2025 56.6 million - 197.0 million -
June 30, 2025 34.6 million - 205.0 million -

ICLR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.1 billion 1.6 billion
Dec. 31, 2025 2.1 billion 1.6 billion
Sept. 30, 2025 2.0 billion 1.6 billion
June 30, 2025 2.0 billion 1.5 billion

ICLR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ICLR

Price: $166.62

52 week price:
66.57
211.00

Earnings Per Share: 2.90 USD

P/E Ratio: 48.53

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: Ireland

Volume: 457160

Ebitda: 105.9 million

Market Capitalization: 13.3 billion

Links: